Global Lung Cancer Biomarkers Market Insights, Forecast to 2029

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Lung Cancer Biomarkers Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Lung Cancer Biomarkers Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
  • 1.2.2 Protein Biomarker
  • 1.2.3 Genetic Biomarker
• 1.3 Market by Application
  • 1.3.1 Global Lung Cancer Biomarkers Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
  • 1.3.2 Diagnostics
  • 1.3.3 Research
  • 1.3.4 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Lung Cancer Biomarkers Sales Estimates and Forecasts 2018-2029
• 2.2 Global Lung Cancer Biomarkers Revenue by Region
  • 2.2.1 Global Lung Cancer Biomarkers Revenue by Region: 2018 VS 2022 VS 2029
  • 2.2.2 Global Lung Cancer Biomarkers Revenue by Region (2018-2023)
  • 2.2.3 Global Lung Cancer Biomarkers Revenue by Region (2024-2029)
  • 2.2.4 Global Lung Cancer Biomarkers Revenue Market Share by Region (2018-2029)
• 2.3 Global Lung Cancer Biomarkers Sales Estimates and Forecasts 2018-2029
• 2.4 Global Lung Cancer Biomarkers Sales by Region
  • 2.4.1 Global Lung Cancer Biomarkers Sales by Region: 2018 VS 2022 VS 2029
  • 2.4.2 Global Lung Cancer Biomarkers Sales by Region (2018-2023)
  • 2.4.3 Global Lung Cancer Biomarkers Sales by Region (2024-2029)
  • 2.4.4 Global Lung Cancer Biomarkers Sales Market Share by Region (2018-2029)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

• 3.1 Global Lung Cancer Biomarkers Sales by Manufacturers
  • 3.1.1 Global Lung Cancer Biomarkers Sales by Manufacturers (2018-2023)
  • 3.1.2 Global Lung Cancer Biomarkers Sales Market Share by Manufacturers (2018-2023)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Lung Cancer Biomarkers in 2022
• 3.2 Global Lung Cancer Biomarkers Revenue by Manufacturers
  • 3.2.1 Global Lung Cancer Biomarkers Revenue by Manufacturers (2018-2023)
  • 3.2.2 Global Lung Cancer Biomarkers Revenue Market Share by Manufacturers (2018-2023)
  • 3.2.3 Global Top 10 and Top 5 Companies by Lung Cancer Biomarkers Revenue in 2022
• 3.3 Global Key Players of Lung Cancer Biomarkers, Industry Ranking, 2021 VS 2022 VS 2023
• 3.4 Global Lung Cancer Biomarkers Sales Price by Manufacturers
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Lung Cancer Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Lung Cancer Biomarkers, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Lung Cancer Biomarkers, Product Offered and Application
• 3.8 Global Key Manufacturers of Lung Cancer Biomarkers, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Lung Cancer Biomarkers Sales by Type
  • 4.1.1 Global Lung Cancer Biomarkers Historical Sales by Type (2018-2023)
  • 4.1.2 Global Lung Cancer Biomarkers Forecasted Sales by Type (2024-2029)
  • 4.1.3 Global Lung Cancer Biomarkers Sales Market Share by Type (2018-2029)
• 4.2 Global Lung Cancer Biomarkers Revenue by Type
  • 4.2.1 Global Lung Cancer Biomarkers Historical Revenue by Type (2018-2023)
  • 4.2.2 Global Lung Cancer Biomarkers Forecasted Revenue by Type (2024-2029)
  • 4.2.3 Global Lung Cancer Biomarkers Revenue Market Share by Type (2018-2029)
• 4.3 Global Lung Cancer Biomarkers Price by Type
  • 4.3.1 Global Lung Cancer Biomarkers Price by Type (2018-2023)
  • 4.3.2 Global Lung Cancer Biomarkers Price Forecast by Type (2024-2029)

5 Market Size by Application

• 5.1 Global Lung Cancer Biomarkers Sales by Application
  • 5.1.1 Global Lung Cancer Biomarkers Historical Sales by Application (2018-2023)
  • 5.1.2 Global Lung Cancer Biomarkers Forecasted Sales by Application (2024-2029)
  • 5.1.3 Global Lung Cancer Biomarkers Sales Market Share by Application (2018-2029)
• 5.2 Global Lung Cancer Biomarkers Revenue by Application
  • 5.2.1 Global Lung Cancer Biomarkers Historical Revenue by Application (2018-2023)
  • 5.2.2 Global Lung Cancer Biomarkers Forecasted Revenue by Application (2024-2029)
  • 5.2.3 Global Lung Cancer Biomarkers Revenue Market Share by Application (2018-2029)
• 5.3 Global Lung Cancer Biomarkers Price by Application
  • 5.3.1 Global Lung Cancer Biomarkers Price by Application (2018-2023)
  • 5.3.2 Global Lung Cancer Biomarkers Price Forecast by Application (2024-2029)

6 US & Canada

• 6.1 US & Canada Lung Cancer Biomarkers Market Size by Type
  • 6.1.1 US & Canada Lung Cancer Biomarkers Sales by Type (2018-2029)
  • 6.1.2 US & Canada Lung Cancer Biomarkers Revenue by Type (2018-2029)
• 6.2 US & Canada Lung Cancer Biomarkers Market Size by Application
  • 6.2.1 US & Canada Lung Cancer Biomarkers Sales by Application (2018-2029)
  • 6.2.2 US & Canada Lung Cancer Biomarkers Revenue by Application (2018-2029)
• 6.3 US & Canada Lung Cancer Biomarkers Market Size by Country
  • 6.3.1 US & Canada Lung Cancer Biomarkers Revenue by Country: 2018 VS 2022 VS 2029
  • 6.3.2 US & Canada Lung Cancer Biomarkers Sales by Country (2018-2029)
  • 6.3.3 US & Canada Lung Cancer Biomarkers Revenue by Country (2018-2029)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Lung Cancer Biomarkers Market Size by Type
  • 7.1.1 Europe Lung Cancer Biomarkers Sales by Type (2018-2029)
  • 7.1.2 Europe Lung Cancer Biomarkers Revenue by Type (2018-2029)
• 7.2 Europe Lung Cancer Biomarkers Market Size by Application
  • 7.2.1 Europe Lung Cancer Biomarkers Sales by Application (2018-2029)
  • 7.2.2 Europe Lung Cancer Biomarkers Revenue by Application (2018-2029)
• 7.3 Europe Lung Cancer Biomarkers Market Size by Country
  • 7.3.1 Europe Lung Cancer Biomarkers Revenue by Country: 2018 VS 2022 VS 2029
  • 7.3.2 Europe Lung Cancer Biomarkers Sales by Country (2018-2029)
  • 7.3.3 Europe Lung Cancer Biomarkers Revenue by Country (2018-2029)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Lung Cancer Biomarkers Market Size
  • 8.1.1 China Lung Cancer Biomarkers Sales (2018-2029)
  • 8.1.2 China Lung Cancer Biomarkers Revenue (2018-2029)
• 8.2 China Lung Cancer Biomarkers Market Size by Application
  • 8.2.1 China Lung Cancer Biomarkers Sales by Application (2018-2029)
  • 8.2.2 China Lung Cancer Biomarkers Revenue by Application (2018-2029)

9 Asia (excluding China)

• 9.1 Asia Lung Cancer Biomarkers Market Size by Type
  • 9.1.1 Asia Lung Cancer Biomarkers Sales by Type (2018-2029)
  • 9.1.2 Asia Lung Cancer Biomarkers Revenue by Type (2018-2029)
• 9.2 Asia Lung Cancer Biomarkers Market Size by Application
  • 9.2.1 Asia Lung Cancer Biomarkers Sales by Application (2018-2029)
  • 9.2.2 Asia Lung Cancer Biomarkers Revenue by Application (2018-2029)
• 9.3 Asia Lung Cancer Biomarkers Sales by Region
  • 9.3.1 Asia Lung Cancer Biomarkers Revenue by Region: 2018 VS 2022 VS 2029
  • 9.3.2 Asia Lung Cancer Biomarkers Revenue by Region (2018-2029)
  • 9.3.3 Asia Lung Cancer Biomarkers Sales by Region (2018-2029)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Lung Cancer Biomarkers Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Lung Cancer Biomarkers Sales by Type (2018-2029)
  • 10.1.2 Middle East, Africa and Latin America Lung Cancer Biomarkers Revenue by Type (2018-2029)
• 10.2 Middle East, Africa and Latin America Lung Cancer Biomarkers Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Lung Cancer Biomarkers Sales by Application (2018-2029)
  • 10.2.2 Middle East, Africa and Latin America Lung Cancer Biomarkers Revenue by Application (2018-2029)
• 10.3 Middle East, Africa and Latin America Lung Cancer Biomarkers Sales by Country
  • 10.3.1 Middle East, Africa and Latin America Lung Cancer Biomarkers Revenue by Country: 2018 VS 2022 VS 2029
  • 10.3.2 Middle East, Africa and Latin America Lung Cancer Biomarkers Revenue by Country (2018-2029)
  • 10.3.3 Middle East, Africa and Latin America Lung Cancer Biomarkers Sales by Country (2018-2029)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Company Profiles

• 11.1 Bio-Rad Laboratories
  • 11.1.1 Bio-Rad Laboratories Company Information
  • 11.1.2 Bio-Rad Laboratories Overview
  • 11.1.3 Bio-Rad Laboratories Lung Cancer Biomarkers Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.1.4 Bio-Rad Laboratories Lung Cancer Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Bio-Rad Laboratories Recent Developments
• 11.2 Roche Diagnostics
  • 11.2.1 Roche Diagnostics Company Information
  • 11.2.2 Roche Diagnostics Overview
  • 11.2.3 Roche Diagnostics Lung Cancer Biomarkers Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.2.4 Roche Diagnostics Lung Cancer Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Roche Diagnostics Recent Developments
• 11.3 Qiagen
  • 11.3.1 Qiagen Company Information
  • 11.3.2 Qiagen Overview
  • 11.3.3 Qiagen Lung Cancer Biomarkers Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.3.4 Qiagen Lung Cancer Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Qiagen Recent Developments
• 11.4 Illumina
  • 11.4.1 Illumina Company Information
  • 11.4.2 Illumina Overview
  • 11.4.3 Illumina Lung Cancer Biomarkers Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.4.4 Illumina Lung Cancer Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Illumina Recent Developments
• 11.5 GE Healthcare
  • 11.5.1 GE Healthcare Company Information
  • 11.5.2 GE Healthcare Overview
  • 11.5.3 GE Healthcare Lung Cancer Biomarkers Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.5.4 GE Healthcare Lung Cancer Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 GE Healthcare Recent Developments
• 11.6 Agilent Technologies
  • 11.6.1 Agilent Technologies Company Information
  • 11.6.2 Agilent Technologies Overview
  • 11.6.3 Agilent Technologies Lung Cancer Biomarkers Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.6.4 Agilent Technologies Lung Cancer Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Agilent Technologies Recent Developments
• 11.7 Biomerieux SA
  • 11.7.1 Biomerieux SA Company Information
  • 11.7.2 Biomerieux SA Overview
  • 11.7.3 Biomerieux SA Lung Cancer Biomarkers Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.7.4 Biomerieux SA Lung Cancer Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Biomerieux SA Recent Developments
• 11.8 Merck
  • 11.8.1 Merck Company Information
  • 11.8.2 Merck Overview
  • 11.8.3 Merck Lung Cancer Biomarkers Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.8.4 Merck Lung Cancer Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Merck Recent Developments
• 11.9 Abbott Laboratories
  • 11.9.1 Abbott Laboratories Company Information
  • 11.9.2 Abbott Laboratories Overview
  • 11.9.3 Abbott Laboratories Lung Cancer Biomarkers Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.9.4 Abbott Laboratories Lung Cancer Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Abbott Laboratories Recent Developments
• 11.10 Becton, Dickinson and Company
  • 11.10.1 Becton, Dickinson and Company Company Information
  • 11.10.2 Becton, Dickinson and Company Overview
  • 11.10.3 Becton, Dickinson and Company Lung Cancer Biomarkers Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.10.4 Becton, Dickinson and Company Lung Cancer Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Becton, Dickinson and Company Recent Developments
• 11.11 Danaher Corporation
  • 11.11.1 Danaher Corporation Company Information
  • 11.11.2 Danaher Corporation Overview
  • 11.11.3 Danaher Corporation Lung Cancer Biomarkers Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.11.4 Danaher Corporation Lung Cancer Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Danaher Corporation Recent Developments
• 11.12 Myriad Genetics
  • 11.12.1 Myriad Genetics Company Information
  • 11.12.2 Myriad Genetics Overview
  • 11.12.3 Myriad Genetics Lung Cancer Biomarkers Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.12.4 Myriad Genetics Lung Cancer Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Myriad Genetics Recent Developments
• 11.13 Sysmex Corporation
  • 11.13.1 Sysmex Corporation Company Information
  • 11.13.2 Sysmex Corporation Overview
  • 11.13.3 Sysmex Corporation Lung Cancer Biomarkers Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.13.4 Sysmex Corporation Lung Cancer Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.13.5 Sysmex Corporation Recent Developments
• 11.14 Hologic
  • 11.14.1 Hologic Company Information
  • 11.14.2 Hologic Overview
  • 11.14.3 Hologic Lung Cancer Biomarkers Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.14.4 Hologic Lung Cancer Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.14.5 Hologic Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Lung Cancer Biomarkers Industry Chain Analysis
• 12.2 Lung Cancer Biomarkers Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Lung Cancer Biomarkers Production Mode & Process
• 12.4 Lung Cancer Biomarkers Sales and Marketing
  • 12.4.1 Lung Cancer Biomarkers Sales Channels
  • 12.4.2 Lung Cancer Biomarkers Distributors
• 12.5 Lung Cancer Biomarkers Customers

13 Market Dynamics

• 13.1 Lung Cancer Biomarkers Industry Trends
• 13.2 Lung Cancer Biomarkers Market Drivers
• 13.3 Lung Cancer Biomarkers Market Challenges
• 13.4 Lung Cancer Biomarkers Market Restraints

14 Key Findings in The Global Lung Cancer Biomarkers Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

• Table 1. Global Lung Cancer Biomarkers Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
• Table 2. Major Manufacturers of Protein Biomarker
• Table 3. Major Manufacturers of Genetic Biomarker
• Table 4. Global Lung Cancer Biomarkers Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Table 5. Global Lung Cancer Biomarkers Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Table 6. Global Lung Cancer Biomarkers Revenue by Region (2018-2023) & (US$ Million)
• Table 7. Global Lung Cancer Biomarkers Revenue by Region (2024-2029) & (US$ Million)
• Table 8. Global Lung Cancer Biomarkers Revenue Market Share by Region (2018-2023)
• Table 9. Global Lung Cancer Biomarkers Revenue Market Share by Region (2024-2029)
• Table 10. Global Lung Cancer Biomarkers Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Table 11. Global Lung Cancer Biomarkers Sales by Region (2018-2023) & (Units)
• Table 12. Global Lung Cancer Biomarkers Sales by Region (2024-2029) & (Units)
• Table 13. Global Lung Cancer Biomarkers Sales Market Share by Region (2018-2023)
• Table 14. Global Lung Cancer Biomarkers Sales Market Share by Region (2024-2029)
• Table 15. Global Lung Cancer Biomarkers Sales by Manufacturers (2018-2023) & (Units)
• Table 16. Global Lung Cancer Biomarkers Sales Share by Manufacturers (2018-2023)
• Table 17. Global Lung Cancer Biomarkers Revenue by Manufacturers (2018-2023) & (US$ Million)
• Table 18. Global Lung Cancer Biomarkers Revenue Share by Manufacturers (2018-2023)
• Table 19. Global Key Players of Lung Cancer Biomarkers, Industry Ranking, 2021 VS 2022 VS 2023
• Table 20. Lung Cancer Biomarkers Price by Manufacturers 2018-2023 (US$/Unit)
• Table 21. Global Lung Cancer Biomarkers Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 22. Global Lung Cancer Biomarkers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Biomarkers as of 2022)
• Table 23. Global Key Manufacturers of Lung Cancer Biomarkers, Manufacturing Base Distribution and Headquarters
• Table 24. Global Key Manufacturers of Lung Cancer Biomarkers, Product Offered and Application
• Table 25. Global Key Manufacturers of Lung Cancer Biomarkers, Date of Enter into This Industry
• Table 26. Mergers & Acquisitions, Expansion Plans
• Table 27. Global Lung Cancer Biomarkers Sales by Type (2018-2023) & (Units)
• Table 28. Global Lung Cancer Biomarkers Sales by Type (2024-2029) & (Units)
• Table 29. Global Lung Cancer Biomarkers Sales Share by Type (2018-2023)
• Table 30. Global Lung Cancer Biomarkers Sales Share by Type (2024-2029)
• Table 31. Global Lung Cancer Biomarkers Revenue by Type (2018-2023) & (US$ Million)
• Table 32. Global Lung Cancer Biomarkers Revenue by Type (2024-2029) & (US$ Million)
• Table 33. Global Lung Cancer Biomarkers Revenue Share by Type (2018-2023)
• Table 34. Global Lung Cancer Biomarkers Revenue Share by Type (2024-2029)
• Table 35. Lung Cancer Biomarkers Price by Type (2018-2023) & (US$/Unit)
• Table 36. Global Lung Cancer Biomarkers Price Forecast by Type (2024-2029) & (US$/Unit)
• Table 37. Global Lung Cancer Biomarkers Sales by Application (2018-2023) & (Units)
• Table 38. Global Lung Cancer Biomarkers Sales by Application (2024-2029) & (Units)
• Table 39. Global Lung Cancer Biomarkers Sales Share by Application (2018-2023)
• Table 40. Global Lung Cancer Biomarkers Sales Share by Application (2024-2029)
• Table 41. Global Lung Cancer Biomarkers Revenue by Application (2018-2023) & (US$ Million)
• Table 42. Global Lung Cancer Biomarkers Revenue by Application (2024-2029) & (US$ Million)
• Table 43. Global Lung Cancer Biomarkers Revenue Share by Application (2018-2023)
• Table 44. Global Lung Cancer Biomarkers Revenue Share by Application (2024-2029)
• Table 45. Lung Cancer Biomarkers Price by Application (2018-2023) & (US$/Unit)
• Table 46. Global Lung Cancer Biomarkers Price Forecast by Application (2024-2029) & (US$/Unit)
• Table 47. US & Canada Lung Cancer Biomarkers Sales by Type (2018-2023) & (Units)
• Table 48. US & Canada Lung Cancer Biomarkers Sales by Type (2024-2029) & (Units)
• Table 49. US & Canada Lung Cancer Biomarkers Revenue by Type (2018-2023) & (US$ Million)
• Table 50. US & Canada Lung Cancer Biomarkers Revenue by Type (2024-2029) & (US$ Million)
• Table 51. US & Canada Lung Cancer Biomarkers Sales by Application (2018-2023) & (Units)
• Table 52. US & Canada Lung Cancer Biomarkers Sales by Application (2024-2029) & (Units)
• Table 53. US & Canada Lung Cancer Biomarkers Revenue by Application (2018-2023) & (US$ Million)
• Table 54. US & Canada Lung Cancer Biomarkers Revenue by Application (2024-2029) & (US$ Million)
• Table 55. US & Canada Lung Cancer Biomarkers Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 56. US & Canada Lung Cancer Biomarkers Revenue by Country (2018-2023) & (US$ Million)
• Table 57. US & Canada Lung Cancer Biomarkers Revenue by Country (2024-2029) & (US$ Million)
• Table 58. US & Canada Lung Cancer Biomarkers Sales by Country (2018-2023) & (Units)
• Table 59. US & Canada Lung Cancer Biomarkers Sales by Country (2024-2029) & (Units)
• Table 60. Europe Lung Cancer Biomarkers Sales by Type (2018-2023) & (Units)
• Table 61. Europe Lung Cancer Biomarkers Sales by Type (2024-2029) & (Units)
• Table 62. Europe Lung Cancer Biomarkers Revenue by Type (2018-2023) & (US$ Million)
• Table 63. Europe Lung Cancer Biomarkers Revenue by Type (2024-2029) & (US$ Million)
• Table 64. Europe Lung Cancer Biomarkers Sales by Application (2018-2023) & (Units)
• Table 65. Europe Lung Cancer Biomarkers Sales by Application (2024-2029) & (Units)
• Table 66. Europe Lung Cancer Biomarkers Revenue by Application (2018-2023) & (US$ Million)
• Table 67. Europe Lung Cancer Biomarkers Revenue by Application (2024-2029) & (US$ Million)
• Table 68. Europe Lung Cancer Biomarkers Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 69. Europe Lung Cancer Biomarkers Revenue by Country (2018-2023) & (US$ Million)
• Table 70. Europe Lung Cancer Biomarkers Revenue by Country (2024-2029) & (US$ Million)
• Table 71. Europe Lung Cancer Biomarkers Sales by Country (2018-2023) & (Units)
• Table 72. Europe Lung Cancer Biomarkers Sales by Country (2024-2029) & (Units)
• Table 73. China Lung Cancer Biomarkers Sales by Type (2018-2023) & (Units)
• Table 74. China Lung Cancer Biomarkers Sales by Type (2024-2029) & (Units)
• Table 75. China Lung Cancer Biomarkers Revenue by Type (2018-2023) & (US$ Million)
• Table 76. China Lung Cancer Biomarkers Revenue by Type (2024-2029) & (US$ Million)
• Table 77. China Lung Cancer Biomarkers Sales by Application (2018-2023) & (Units)
• Table 78. China Lung Cancer Biomarkers Sales by Application (2024-2029) & (Units)
• Table 79. China Lung Cancer Biomarkers Revenue by Application (2018-2023) & (US$ Million)
• Table 80. China Lung Cancer Biomarkers Revenue by Application (2024-2029) & (US$ Million)
• Table 81. Asia Lung Cancer Biomarkers Sales by Type (2018-2023) & (Units)
• Table 82. Asia Lung Cancer Biomarkers Sales by Type (2024-2029) & (Units)
• Table 83. Asia Lung Cancer Biomarkers Revenue by Type (2018-2023) & (US$ Million)
• Table 84. Asia Lung Cancer Biomarkers Revenue by Type (2024-2029) & (US$ Million)
• Table 85. Asia Lung Cancer Biomarkers Sales by Application (2018-2023) & (Units)
• Table 86. Asia Lung Cancer Biomarkers Sales by Application (2024-2029) & (Units)
• Table 87. Asia Lung Cancer Biomarkers Revenue by Application (2018-2023) & (US$ Million)
• Table 88. Asia Lung Cancer Biomarkers Revenue by Application (2024-2029) & (US$ Million)
• Table 89. Asia Lung Cancer Biomarkers Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 90. Asia Lung Cancer Biomarkers Revenue by Region (2018-2023) & (US$ Million)
• Table 91. Asia Lung Cancer Biomarkers Revenue by Region (2024-2029) & (US$ Million)
• Table 92. Asia Lung Cancer Biomarkers Sales by Region (2018-2023) & (Units)
• Table 93. Asia Lung Cancer Biomarkers Sales by Region (2024-2029) & (Units)
• Table 94. Middle East, Africa and Latin America Lung Cancer Biomarkers Sales by Type (2018-2023) & (Units)
• Table 95. Middle East, Africa and Latin America Lung Cancer Biomarkers Sales by Type (2024-2029) & (Units)
• Table 96. Middle East, Africa and Latin America Lung Cancer Biomarkers Revenue by Type (2018-2023) & (US$ Million)
• Table 97. Middle East, Africa and Latin America Lung Cancer Biomarkers Revenue by Type (2024-2029) & (US$ Million)
• Table 98. Middle East, Africa and Latin America Lung Cancer Biomarkers Sales by Application (2018-2023) & (Units)
• Table 99. Middle East, Africa and Latin America Lung Cancer Biomarkers Sales by Application (2024-2029) & (Units)
• Table 100. Middle East, Africa and Latin America Lung Cancer Biomarkers Revenue by Application (2018-2023) & (US$ Million)
• Table 101. Middle East, Africa and Latin America Lung Cancer Biomarkers Revenue by Application (2024-2029) & (US$ Million)
• Table 102. Middle East, Africa and Latin America Lung Cancer Biomarkers Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 103. Middle East, Africa and Latin America Lung Cancer Biomarkers Revenue by Country (2018-2023) & (US$ Million)
• Table 104. Middle East, Africa and Latin America Lung Cancer Biomarkers Revenue by Country (2024-2029) & (US$ Million)
• Table 105. Middle East, Africa and Latin America Lung Cancer Biomarkers Sales by Country (2018-2023) & (Units)
• Table 106. Middle East, Africa and Latin America Lung Cancer Biomarkers Sales by Country (2024-2029) & (Units)
• Table 107. Bio-Rad Laboratories Company Information
• Table 108. Bio-Rad Laboratories Description and Major Businesses
• Table 109. Bio-Rad Laboratories Lung Cancer Biomarkers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 110. Bio-Rad Laboratories Lung Cancer Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
• Table 111. Bio-Rad Laboratories Recent Developments
• Table 112. Roche Diagnostics Company Information
• Table 113. Roche Diagnostics Description and Major Businesses
• Table 114. Roche Diagnostics Lung Cancer Biomarkers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 115. Roche Diagnostics Lung Cancer Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
• Table 116. Roche Diagnostics Recent Developments
• Table 117. Qiagen Company Information
• Table 118. Qiagen Description and Major Businesses
• Table 119. Qiagen Lung Cancer Biomarkers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 120. Qiagen Lung Cancer Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
• Table 121. Qiagen Recent Developments
• Table 122. Illumina Company Information
• Table 123. Illumina Description and Major Businesses
• Table 124. Illumina Lung Cancer Biomarkers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 125. Illumina Lung Cancer Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
• Table 126. Illumina Recent Developments
• Table 127. GE Healthcare Company Information
• Table 128. GE Healthcare Description and Major Businesses
• Table 129. GE Healthcare Lung Cancer Biomarkers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 130. GE Healthcare Lung Cancer Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
• Table 131. GE Healthcare Recent Developments
• Table 132. Agilent Technologies Company Information
• Table 133. Agilent Technologies Description and Major Businesses
• Table 134. Agilent Technologies Lung Cancer Biomarkers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 135. Agilent Technologies Lung Cancer Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
• Table 136. Agilent Technologies Recent Developments
• Table 137. Biomerieux SA Company Information
• Table 138. Biomerieux SA Description and Major Businesses
• Table 139. Biomerieux SA Lung Cancer Biomarkers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 140. Biomerieux SA Lung Cancer Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
• Table 141. Biomerieux SA Recent Developments
• Table 142. Merck Company Information
• Table 143. Merck Description and Major Businesses
• Table 144. Merck Lung Cancer Biomarkers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 145. Merck Lung Cancer Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
• Table 146. Merck Recent Developments
• Table 147. Abbott Laboratories Company Information
• Table 148. Abbott Laboratories Description and Major Businesses
• Table 149. Abbott Laboratories Lung Cancer Biomarkers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 150. Abbott Laboratories Lung Cancer Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
• Table 151. Abbott Laboratories Recent Developments
• Table 152. Becton, Dickinson and Company Company Information
• Table 153. Becton, Dickinson and Company Description and Major Businesses
• Table 154. Becton, Dickinson and Company Lung Cancer Biomarkers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 155. Becton, Dickinson and Company Lung Cancer Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
• Table 156. Becton, Dickinson and Company Recent Developments
• Table 157. Danaher Corporation Company Information
• Table 158. Danaher Corporation Description and Major Businesses
• Table 159. Danaher Corporation Lung Cancer Biomarkers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 160. Danaher Corporation Lung Cancer Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
• Table 161. Danaher Corporation Recent Developments
• Table 162. Myriad Genetics Company Information
• Table 163. Myriad Genetics Description and Major Businesses
• Table 164. Myriad Genetics Lung Cancer Biomarkers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 165. Myriad Genetics Lung Cancer Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
• Table 166. Myriad Genetics Recent Developments
• Table 167. Sysmex Corporation Company Information
• Table 168. Sysmex Corporation Description and Major Businesses
• Table 169. Sysmex Corporation Lung Cancer Biomarkers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 170. Sysmex Corporation Lung Cancer Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
• Table 171. Sysmex Corporation Recent Developments
• Table 172. Hologic Company Information
• Table 173. Hologic Description and Major Businesses
• Table 174. Hologic Lung Cancer Biomarkers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 175. Hologic Lung Cancer Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
• Table 176. Hologic Recent Developments
• Table 177. Key Raw Materials Lists
• Table 178. Raw Materials Key Suppliers Lists
• Table 179. Lung Cancer Biomarkers Distributors List
• Table 180. Lung Cancer Biomarkers Customers List
• Table 181. Lung Cancer Biomarkers Market Trends
• Table 182. Lung Cancer Biomarkers Market Drivers
• Table 183. Lung Cancer Biomarkers Market Challenges
• Table 184. Lung Cancer Biomarkers Market Restraints
• Table 185. Research Programs/Design for This Report
• Table 186. Key Data Information from Secondary Sources
• Table 187. Key Data Information from Primary Sources

List of Figures

• Figure 1. Lung Cancer Biomarkers Product Picture
• Figure 2. Global Lung Cancer Biomarkers Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 3. Global Lung Cancer Biomarkers Market Share by Type in 2022 & 2029
• Figure 4. Protein Biomarker Product Picture
• Figure 5. Genetic Biomarker Product Picture
• Figure 6. Global Lung Cancer Biomarkers Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 7. Global Lung Cancer Biomarkers Market Share by Application in 2022 & 2029
• Figure 8. Diagnostics
• Figure 9. Research
• Figure 10. Others
• Figure 11. Lung Cancer Biomarkers Report Years Considered
• Figure 12. Global Lung Cancer Biomarkers Revenue, (US$ Million), 2018 VS 2022 VS 2029
• Figure 13. Global Lung Cancer Biomarkers Revenue 2018-2029 (US$ Million)
• Figure 14. Global Lung Cancer Biomarkers Revenue Market Share by Region in Percentage: 2022 Versus 2029
• Figure 15. Global Lung Cancer Biomarkers Revenue Market Share by Region (2018-2029)
• Figure 16. Global Lung Cancer Biomarkers Sales 2018-2029 ((Units)
• Figure 17. Global Lung Cancer Biomarkers Sales Market Share by Region (2018-2029)
• Figure 18. US & Canada Lung Cancer Biomarkers Sales YoY (2018-2029) & (Units)
• Figure 19. US & Canada Lung Cancer Biomarkers Revenue YoY (2018-2029) & (US$ Million)
• Figure 20. Europe Lung Cancer Biomarkers Sales YoY (2018-2029) & (Units)
• Figure 21. Europe Lung Cancer Biomarkers Revenue YoY (2018-2029) & (US$ Million)
• Figure 22. China Lung Cancer Biomarkers Sales YoY (2018-2029) & (Units)
• Figure 23. China Lung Cancer Biomarkers Revenue YoY (2018-2029) & (US$ Million)
• Figure 24. Asia (excluding China) Lung Cancer Biomarkers Sales YoY (2018-2029) & (Units)
• Figure 25. Asia (excluding China) Lung Cancer Biomarkers Revenue YoY (2018-2029) & (US$ Million)
• Figure 26. Middle East, Africa and Latin America Lung Cancer Biomarkers Sales YoY (2018-2029) & (Units)
• Figure 27. Middle East, Africa and Latin America Lung Cancer Biomarkers Revenue YoY (2018-2029) & (US$ Million)
• Figure 28. The Lung Cancer Biomarkers Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
• Figure 29. The Top 5 and 10 Largest Manufacturers of Lung Cancer Biomarkers in the World: Market Share by Lung Cancer Biomarkers Revenue in 2022
• Figure 30. Global Lung Cancer Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
• Figure 31. Global Lung Cancer Biomarkers Sales Market Share by Type (2018-2029)
• Figure 32. Global Lung Cancer Biomarkers Revenue Market Share by Type (2018-2029)
• Figure 33. Global Lung Cancer Biomarkers Sales Market Share by Application (2018-2029)
• Figure 34. Global Lung Cancer Biomarkers Revenue Market Share by Application (2018-2029)
• Figure 35. US & Canada Lung Cancer Biomarkers Sales Market Share by Type (2018-2029)
• Figure 36. US & Canada Lung Cancer Biomarkers Revenue Market Share by Type (2018-2029)
• Figure 37. US & Canada Lung Cancer Biomarkers Sales Market Share by Application (2018-2029)
• Figure 38. US & Canada Lung Cancer Biomarkers Revenue Market Share by Application (2018-2029)
• Figure 39. US & Canada Lung Cancer Biomarkers Revenue Share by Country (2018-2029)
• Figure 40. US & Canada Lung Cancer Biomarkers Sales Share by Country (2018-2029)
• Figure 41. U.S. Lung Cancer Biomarkers Revenue (2018-2029) & (US$ Million)
• Figure 42. Canada Lung Cancer Biomarkers Revenue (2018-2029) & (US$ Million)
• Figure 43. Europe Lung Cancer Biomarkers Sales Market Share by Type (2018-2029)
• Figure 44. Europe Lung Cancer Biomarkers Revenue Market Share by Type (2018-2029)
• Figure 45. Europe Lung Cancer Biomarkers Sales Market Share by Application (2018-2029)
• Figure 46. Europe Lung Cancer Biomarkers Revenue Market Share by Application (2018-2029)
• Figure 47. Europe Lung Cancer Biomarkers Revenue Share by Country (2018-2029)
• Figure 48. Europe Lung Cancer Biomarkers Sales Share by Country (2018-2029)
• Figure 49. Germany Lung Cancer Biomarkers Revenue (2018-2029) & (US$ Million)
• Figure 50. France Lung Cancer Biomarkers Revenue (2018-2029) & (US$ Million)
• Figure 51. U.K. Lung Cancer Biomarkers Revenue (2018-2029) & (US$ Million)
• Figure 52. Italy Lung Cancer Biomarkers Revenue (2018-2029) & (US$ Million)
• Figure 53. Russia Lung Cancer Biomarkers Revenue (2018-2029) & (US$ Million)
• Figure 54. China Lung Cancer Biomarkers Sales Market Share by Type (2018-2029)
• Figure 55. China Lung Cancer Biomarkers Revenue Market Share by Type (2018-2029)
• Figure 56. China Lung Cancer Biomarkers Sales Market Share by Application (2018-2029)
• Figure 57. China Lung Cancer Biomarkers Revenue Market Share by Application (2018-2029)
• Figure 58. Asia Lung Cancer Biomarkers Sales Market Share by Type (2018-2029)
• Figure 59. Asia Lung Cancer Biomarkers Revenue Market Share by Type (2018-2029)
• Figure 60. Asia Lung Cancer Biomarkers Sales Market Share by Application (2018-2029)
• Figure 61. Asia Lung Cancer Biomarkers Revenue Market Share by Application (2018-2029)
• Figure 62. Asia Lung Cancer Biomarkers Revenue Share by Region (2018-2029)
• Figure 63. Asia Lung Cancer Biomarkers Sales Share by Region (2018-2029)
• Figure 64. Japan Lung Cancer Biomarkers Revenue (2018-2029) & (US$ Million)
• Figure 65. South Korea Lung Cancer Biomarkers Revenue (2018-2029) & (US$ Million)
• Figure 66. China Taiwan Lung Cancer Biomarkers Revenue (2018-2029) & (US$ Million)
• Figure 67. Southeast Asia Lung Cancer Biomarkers Revenue (2018-2029) & (US$ Million)
• Figure 68. India Lung Cancer Biomarkers Revenue (2018-2029) & (US$ Million)
• Figure 69. Middle East, Africa and Latin America Lung Cancer Biomarkers Sales Market Share by Type (2018-2029)
• Figure 70. Middle East, Africa and Latin America Lung Cancer Biomarkers Revenue Market Share by Type (2018-2029)
• Figure 71. Middle East, Africa and Latin America Lung Cancer Biomarkers Sales Market Share by Application (2018-2029)
• Figure 72. Middle East, Africa and Latin America Lung Cancer Biomarkers Revenue Market Share by Application (2018-2029)
• Figure 73. Middle East, Africa and Latin America Lung Cancer Biomarkers Revenue Share by Country (2018-2029)
• Figure 74. Middle East, Africa and Latin America Lung Cancer Biomarkers Sales Share by Country (2018-2029)
• Figure 75. Brazil Lung Cancer Biomarkers Revenue (2018-2029) & (US$ Million)
• Figure 76. Mexico Lung Cancer Biomarkers Revenue (2018-2029) & (US$ Million)
• Figure 77. Turkey Lung Cancer Biomarkers Revenue (2018-2029) & (US$ Million)
• Figure 78. Israel Lung Cancer Biomarkers Revenue (2018-2029) & (US$ Million)
• Figure 79. GCC Countries Lung Cancer Biomarkers Revenue (2018-2029) & (US$ Million)
• Figure 80. Lung Cancer Biomarkers Value Chain
• Figure 81. Lung Cancer Biomarkers Production Process
• Figure 82. Channels of Distribution
• Figure 83. Distributors Profiles
• Figure 84. Bottom-up and Top-down Approaches for This Report
• Figure 85. Data Triangulation
• Figure 86. Key Executives Interviewed